| Targeting heparin and heparan sulfate protein interactions RJ Weiss, JD Esko, Y Tor Organic & biomolecular chemistry 15 (27), 5656-5668, 2017 | 141 | 2017 |
| PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens PN Spahn, T Bath, RJ Weiss, J Kim, JD Esko, NE Lewis, O Harismendy Scientific reports 7 (1), 15854, 2017 | 85 | 2017 |
| ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis RJ Weiss, PN Spahn, AG Toledo, AWT Chiang, BP Kellman, J Li, ... Proceedings of the National Academy of Sciences 117 (17), 9311-9317, 2020 | 43 | 2020 |
| Small molecule antagonists of cell-surface heparan sulfate and heparin–protein interactions RJ Weiss, PLSM Gordts, D Le, D Xu, JD Esko, Y Tor Chemical science 6 (10), 5984-5993, 2015 | 27 | 2015 |
| Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease A Basu, NG Patel, ED Nicholson, RJ Weiss American Journal of Physiology-Cell Physiology 322 (5), C849-C864, 2022 | 20 | 2022 |
| Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate RJ Weiss, PN Spahn, AWT Chiang, Q Liu, J Li, KM Hamill, S Rother, ... Nature chemical biology 17 (6), 684-692, 2021 | 20 | 2021 |
| Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy SM Alavi Naini, C Yanicostas, R Hassan-Abdi, S Blondeel, M Bennis, ... Translational neurodegeneration 7, 1-9, 2018 | 19 | 2018 |
| The prolyl-tRNA synthetase inhibitor halofuginone inhibits SARS-CoV-2 infection DR Sandoval, TM Clausen, C Nora, AP Cribbs, A Denardo, AE Clark, ... bioRxiv, 2021.03. 22.436522, 2021 | 13 | 2021 |
| Rearrangement of 3-membered 1, 1, 2-trifluorobromonium and iodonium ions and comparison of trifluorochloronium to fluorocarbenium ions DF Shellhamer, KJ Davenport, HK Forberg, MP Herrick, RN Jones, ... The Journal of Organic Chemistry 73 (12), 4532-4538, 2008 | 9 | 2008 |
| Drug-induced oedema C Schindler, SM Schellong Phlebologie 38 (01), 33-41, 2009 | 6 | 2009 |
| TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth A Basu, RN Champagne, NG Patel, ED Nicholson, RJ Weiss Journal of Biological Chemistry 299 (6), 2023 | 2 | 2023 |
| Glycosaminoglycan Analysis: Purification, Structural Profiling, and GAG–Protein Interactions A Basu, RJ Weiss Chemokine-Glycosaminoglycan Interactions: Methods and Protocols, 159-176, 2022 | 1 | 2022 |
| Antithrombin heparan sulfate for detection and treatment of cancer R Weiss, TM Clausen, JD Esko US Patent App. 18/257,838, 2024 | | 2024 |
| Heparan sulfate modified proteins affect cellular processes central to neurodegeneration and modulate presenilin function N Schultheis, A Connell, A Kapral, RJ Becker, R Mueller, S Shah, ... bioRxiv, 2024.01. 23.576895, 2024 | | 2024 |
| Exploring the Regulatory Mechanisms of EXT1 and EXT2 for Identifying Drug Targets in Multiple Hereditary Exostoses (MHE) X Dong, K Suryadevara, L Wells, R Weiss GLYCOBIOLOGY 33 (11), 958-958, 2023 | | 2023 |
| Drug Discovery for Sanfilippo Syndrome A Basu, M Intermann, BC Maloney, K Cisneros, AC Russell, CA Rice, ... GLYCOBIOLOGY 33 (11), 957-957, 2023 | | 2023 |
| High Throughput Drug Discovery for Multiple Hereditary Exostoses K Cisneros, M Intemann, H Takeuchi, AC Russell, C Rice, RJ Weiss GLYCOBIOLOGY 33 (11), 957-957, 2023 | | 2023 |
| EZH2 is a Novel Epigenetic Regulator of Heparan Sulfate Biosynthesis N Patel, A Basu, E Spector, R Champagne, E Nicholson, R Weiss GLYCOBIOLOGY 33 (11), 1032-1032, 2023 | | 2023 |
| Targeting Heparan Sulfate Assembly for Drug Discovery in Rare Disease R Weiss GLYCOBIOLOGY 33 (11), 965-965, 2023 | | 2023 |
| Methods and uses of halofuginone PLSM Gordts, A Denardo, RJ Weiss, C Nora, JD Esko, T Mandel-Clausen, ... US Patent App. 18/022,254, 2023 | | 2023 |
